FDG-PET may aid treatment decisions for prostate cancer

07/2/2013 | Renal and Urology News

A study presented at a urological meeting found that in patients with prostate cancer, FDG uptake by the prostate as seen on PET scans may be useful for determining whether to treat with radical prostatectomy. "Since there is a high failure rate with prostatectomy, the presence or absence of FDG uptake can help you decide whether to still do a radical prostatectomy in a morbid patient or just reorient the patient to radiation therapy or androgen deprivation therapy," said lead researcher Dr. Frederic Pouliot from Laval University in Quebec. The team compared results from FDG-PET imaging with those from surgery.

View Full Article in:

Renal and Urology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC